동물용 산소 요법 시장 기회, 성장 촉진요인, 산업 동향 분석 및 예측(2025-2034년)

The Global Veterinary Oxygen Therapy Market was valued at USD 1.2 billion in 2024 and is estimated to grow at a CAGR of 8.5% to reach USD 2.7 billion by 2034. This growth trend reflects a significant transformation in veterinary healthcare as oxygen therapy becomes a core component in treating pets with respiratory disorders and chronic illnesses. Rising awareness about pet health, the humanization of pets, and increased willingness among pet owners to spend on advanced treatment solutions are reinforcing the adoption of oxygen therapy across veterinary settings. Conditions like pneumonia, asthma, chronic obstructive pulmonary disease (COPD), and other respiratory complications are becoming increasingly common, especially in urban environments where pollution levels are high. Veterinary care is undergoing a shift toward more patient-friendly, non-invasive solutions, with oxygen therapy emerging as a reliable method for post-surgical recovery and critical care. In addition to that, the rising prevalence of obesity-related complications and aging pet populations are accelerating the demand for continuous and emergency oxygen support in clinics and at home.

A growing number of veterinary hospitals and specialty clinics are now incorporating advanced oxygen therapy devices such as concentrators, nasal catheters, and high-efficiency oxygen masks to improve survival rates and enhance treatment outcomes. Post-operative complications often require oxygen therapy for stabilized recovery, making it a critical part of intensive veterinary care. Technological innovations, especially the introduction of portable oxygen concentrators, have significantly improved care delivery. These devices offer continuous oxygen flow, making them ideal for both in-clinic and at-home care, particularly for chronic conditions. Compared to traditional oxygen cylinders, portable concentrators are more sustainable and require less maintenance, offering cost-effective solutions for both practitioners and pet owners.

The market is segmented by product type into veterinary oxygen concentrators and accessories. The oxygen concentrator segment alone generated USD 984.5 million in 2024. This includes both stationary and portable devices, which are being increasingly used due to a rise in surgical interventions and emergency respiratory cases. Aging pets often suffer from ailments such as pneumonia, bronchitis, and respiratory distress syndrome, for which oxygen therapy is the preferred method of care. The convenience, efficiency, and eco-friendliness of concentrators have made them a preferred choice among veterinary professionals.

By animal type, the market is categorized into small and large animals, with the small animal segment accounting for a 60% share in 2024. This dominance is linked to the widespread ownership of small pets like pugs, bulldogs, and Persian cats, which are prone to breathing disorders. In North America, the veterinary oxygen therapy market accounted for 39.9% of the global share in 2024, thanks to strong pet healthcare infrastructure, higher pet ownership rates, and growing awareness of chronic respiratory conditions.

Leading companies such as Imex Medical Limited, AEOLUS International Pet Products, Drive DeVilbiss International, Koninklijke Philips, Vetland Medical, RWD Life Science, Airnetic, Shinova Systems, BMV Animal Technology, and Longfian Scitech are shaping the market landscape. These players are prioritizing innovation and investing heavily in research and development to introduce more portable, cost-effective, and efficient oxygen therapy systems. They are also forming strategic alliances with veterinary hospitals and clinics to enhance their service networks and launching cutting-edge devices to address the evolving needs of veterinary care.

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market scope and definition
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Base estimates and calculations
  • 1.3.1 Base year calculation
  • 1.3.2 Key trends for market estimation
• 1.4 Forecast model
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
  • 1.5.2 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360⁰ synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Increasing pet ownership and spending on veterinary care
    • 3.2.1.2 Rising prevalence of respiratory and cardiac diseases in animals
    • 3.2.1.3 Technological advancements in oxygen concentrator
  • 3.2.2 Industry pitfalls and challenges
    • 3.2.2.1 High cost of veterinary oxygen therapy equipment
    • 3.2.2.2 Lack of awareness in developing regions
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
• 3.5 Technology landscape
• 3.6 Porter’s analysis
• 3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2024

• 4.1 Introduction
• 4.2 Company matrix analysis
• 4.3 Competitive analysis of major market players
• 4.4 Competitive positioning matrix
• 4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product, 2021 – 2034 ($ Mn)

• 5.1 Key trends
• 5.2 Veterinary oxygen concentrator
  • 5.2.1 Stationary oxygen concentrator
  • 5.2.2 Portable oxygen concentrator
• 5.3 Accessories

Chapter 6 Market Estimates and Forecast, By Animal Type, 2021 – 2034 ($ Mn)

• 6.1 Key trends
• 6.2 Small animals
• 6.3 Large animals

Chapter 7 Market Estimates and Forecast, By Application, 2021 – 2034 ($ Mn)

• 7.1 Key trends
• 7.2 Intensive care
• 7.3 Homecare setting/postoperative care
• 7.4 Other applications

Chapter 8 Market Estimates and Forecast, By End Use, 2021 – 2034 ($ Mn)

• 8.1 Key trends
• 8.2 Veterinary hospitals
• 8.3 Veterinary clinics
• 8.4 Other end use

Chapter 9 Market Estimates and Forecast, By Region, 2021 – 2034 ($ Mn)

• 9.1 Key trends
• 9.2 North America
  • 9.2.1 U.S.
  • 9.2.2 Canada
• 9.3 Europe
  • 9.3.1 Germany
  • 9.3.2 UK
  • 9.3.3 France
  • 9.3.4 Italy
  • 9.3.5 Spain
  • 9.3.6 Netherlands
• 9.4 Asia Pacific
  • 9.4.1 China
  • 9.4.2 Japan
  • 9.4.3 India
  • 9.4.4 Australia
  • 9.4.5 South Korea
• 9.5 Latin America
  • 9.5.1 Brazil
  • 9.5.2 Mexico
  • 9.5.3 Argentina
• 9.6 Middle East and Africa
  • 9.6.1 South Africa
  • 9.6.2 Saudi Arabia
  • 9.6.3 UAE

Chapter 10 Company Profiles

• 10.1 AEOLUS International Pet Products
• 10.2 Airnetic
• 10.3 BMV Animal Technology
• 10.4 CAIRE
• 10.5 Drive DeVilbiss International
• 10.6 Imex Medical Limited
• 10.7 Koninklijke Philips
• 10.8 Longfian Scitech
• 10.9 RWD Life Science
• 10.10 Shinova Systems
• 10.11 Vetland Medical